A carregar...
Phase I Clinical Trial of Ifosfamide, Oxaliplatin and Etoposide (IOE) in Pediatric Patients with Refractory Solid Tumors
Oxaliplatin, although related to cisplatin and carboplatin, has a more favorable toxicity profile and may offer advantages in combination regimens. We combined oxaliplatin, ifosfamide, and etoposide (IOE) and estimated the regimen's maximum tolerated dose (MTD) in children with refractory solid...
Na minha lista:
| Publicado no: | J Pediatr Hematol Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4269576/ https://ncbi.nlm.nih.gov/pubmed/24942022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000000186 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|